Schlosser Michael J sold $594K of HCA
Schlosser Michael J (EVP and Chief Clinical Officer) sold 1,200 shares of HCA Healthcare, Inc. (HCA) at $494.65 ($0.59M total) on 2026-11-04.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest in size and unlikely to move the stock significantly, but may attract short‑term attention.
Market read
A routine insider sale with limited material impact; traders may note but unlikely to act.
What to watch
The insider retains a large proportion of shares, indicating continued confidence.
Background
Form 4 filings disclose insider transactions and are monitored for potential signals about company prospects.
Ticker impact
EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares for $593,582.88 on 2026-11-04.
likely slight downward pressure as the market prices the insider sell.
The sale is small relative to holdings (1,443 shares remaining) but is a primary Form 4 filing, which traders watch for signals.
Market effects
Minimal impact on the healthcare sector; insider sales are routine.
No regional effect; confined to HCA shareholders.
Low global relevance.
Counterpoint
The sale could be unrelated to company outlook and merely personal diversification.
Key entities
- OfficerMichael J. Schlosser
EVP and Chief Clinical Officer of HCA Healthcare.
- CompanyHCA Healthcare, Inc.
U.S. listed healthcare services provider.
